Press Release Contact
Press release:
Tellus Therapeutics Awarded NINDS SBIR Funding for Development of TT-20 for Treatment of Neonatal Brain Injury
December 07, 2020, 20:19 GMT
For questions about this press release, please contact the person or organization listed below.
Jason Kralic
Tellus Therapeutics, Inc.
+1 919-491-4995
Visit us on social media:
LinkedIn